KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $103,000 | -61.6% | 1,975 | -50.0% | 0.00% | – |
| Q2 2021 | $268,000 | -11.8% | 3,950 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $304,000 | -76.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,304,000 | +667.1% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $170,000 | +3.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $164,000 | +925.0% | 3,950 | +953.3% | 0.00% | – |
| Q1 2020 | $16,000 | -23.8% | 375 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | -89.5% | 375 | -93.5% | 0.00% | -100.0% |
| Q3 2019 | $200,000 | +51.5% | 5,765 | +76.0% | 0.00% | 0.0% |
| Q2 2019 | $132,000 | +22.2% | 3,275 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,000 | +77.0% | 3,275 | +12.0% | 0.00% | 0.0% |
| Q4 2018 | $61,000 | +56.4% | 2,925 | +31.5% | 0.00% | – |
| Q3 2018 | $39,000 | +18.2% | 2,225 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +50.0% | 2,225 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +100.0% | 2,225 | +122.5% | 0.00% | – |
| Q4 2017 | $11,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $31,079,000 | 9.72% |
| Knoll Capital Management, LLC | 120,212 | $4,174,000 | 3.82% |
| S Squared Technology, LLC | 67,533 | $2,345,000 | 2.07% |
| Redmile Group, LLC | 1,078,300 | $37,444,000 | 1.25% |
| EAM Investors, LLC | 87,914 | $3,053,000 | 0.81% |
| Consonance Capital Management LP | 224,090 | $7,782,000 | 0.77% |
| EAM Global Investors LLC | 41,329 | $1,435,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,625 | $4,085,000 | 0.63% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 28,000 | $972,000 | 0.62% |
| Atika Capital Management LLC | 58,319 | $2,026,000 | 0.43% |